Reminders

Microblogs: Patient Engagement

Offline
CanBiotech Inc. said 28 hours ago

Preparing Providers for the Healthcare Consumerism Shift
Developing a customer-focused healthcare consumerism strategy is key to boosting patient experiences and healthcare revenue cycles.
Read More...

Offline
CanBiotech Inc. said 28 hours ago

Healthcare Companies Should Design Patient Experiences Like Customer Experiences
Read More...

Offline
CanBiotech Inc. said 2 weeks ago

Redesigning the Patient Journey through Design Thinking
A design company was hired to speed up the diagnostics time for breast cancer patients in a Norwegian hospital. The result? A reduced waiting time by 90%.
Read More...

Offline
CanBiotech Inc. said 5 weeks ago

GTCbio's Diabetes summit will be showcasing a few patient entrepreneurs working on different aspects of treatment and management of the disease. The summit will be held at the Hyatt Regency on April 5th – 7th, 2017 in Boston, MA. The following entrepreneurs and their companies will be participating in the Patient Entrepreneur Panel:

  • Karin Hehenberger, Founder and CEO of LyfeBulb
    LyfeBulb is dedicated to improve the quality of life of those living with chronic disease through investing in innovation, promoting Patient Entrepeneurs and growing an online community.

  • Charles O’Connell, Founder and CEO of Fitscript
    Fitscript is dedicated to helping people living with diabetes reach their fitness goals by getting rid of the highs and lows, and by getting in the GLUCOSEZONE.

  • Shantanu Gaur, Co-Founder and CSO of Allurion Technologies
    Allurion’s Elipse device is the first procedureless gastric balloon for weight loss. It is swallowed and naturally excreted without surgery, endoscopy, or anesthesia.

  • Matthew Loper, CEO of Wellth
    Wellth helps payers and providers thrive in a value-based environment by paying patients to be healthy, with a goal of ensuring the adoption and success of value-based care.

  • Robert Geho, Co-Founder and CEO of Diasome Pharmaceuticals Inc
    Diasome is developing breakthrough insulin efficacy solutions for people with Type 1 and Type 2 diabetes using hepatocyte targeted nanotechnology based drug delivery systems.

    Read more...

Offline
CanBiotech Inc. said 6 weeks ago

FDA Unveils Patient Safety Analytics Tool for Medical Research
Using a new research tool, healthcare stakeholders will have access to real world evidence and data from Sentinel, the FDA's patient safety surveillance system.
Read More...

Offline
CanBiotech Inc. said 8 weeks ago

Capturing the Value of Patient Engagement: Summary of Results of the Study of Patient-Centric Initiatives in Drug Development
Read this executive summary and detailed study results that include key insights in the following areas: adoption of patient-centric initiatives by pharmaceutical and biotech companies, barriers to adoption of patient-centric initiatives, comparative analytics and results of patient-centric initiatives.

Read More...

Offline
CanBiotech Inc. said 8 weeks ago

Mini-course starter kit – Setting Research Priorities
This EUPATI Mini-course starter kit is designed for patient involvement in setting research priorities.
Read More...

Offline
CanBiotech Inc.:Replied 8 weeks ago
Offline
Offline
Offline

Viewed 1,479 times